José Vicente Castell (Jose V Castell, Jose Vicente Castell, José V Castell)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Intellectual Disability

Gas Chromatography Mass Spectrometry

Top Venues

International journal of molecular sciences

Archives of toxicology

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Moreno-Torres, Guillermo Quintas, Teresa Martínez-Sena, Ramiro Jover, José Vicente Castell
Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. International journal of molecular sciences 25 (5) (2024)
Ernesto López-Pascual, Iván Rienda, Judith Pérez-Rojas, Anna Rapisarda, Guillem Garcia-Llorens, Ramiro Jover, José Vicente Castell
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways. International journal of molecular sciences 25 (10) (2024)
Marta Moreno-Torres, Guillermo Quintas, Teresa Martínez-Sena, Ramiro Jover, José Vicente Castell
Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. International journal of molecular sciences 25 (5) (2024)
Marta Moreno-Torres, Guillermo Quintas, Teresa Martínez-Sena, Ramiro Jover, José Vicente Castell
Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. International journal of molecular sciences 25 (5) (2024)
Ernesto López-Pascual, Iván Rienda, Judith Pérez-Rojas, Anna Rapisarda, Guillem Garcia-Llorens, Ramiro Jover, José Vicente Castell
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways. International journal of molecular sciences 25 (10) (2024)
Ernesto López-Pascual, Iván Rienda, Judith Pérez-Rojas, Anna Rapisarda, Guillem Garcia-Llorens, Ramiro Jover, José Vicente Castell
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways. International journal of molecular sciences 25 (10) (2024)
Teresa Martínez-Sena, Erika Moro, Marta Moreno-Torres, Guillermo Quintás, Jan Hengstler, José Vicente Castell
Metabolomics-based strategy to assess drug hepatotoxicity and uncover the mechanisms of hepatotoxicity involved. Archives of toxicology (2023)
Álvaro Pérez-Rubio, Polina Soluyanova, Erika Moro, Guillermo Quintas, Iván Rienda, María Dolores Periañez, Andrés Painel, José Vizuete, Judith Pérez-Rojas, José Vicente Castell, Ramón Trullenque-Juan, Eugenia Pareja Ibars, Ramiro Jover
Gut Microbiota and Plasma Bile Acids Associated with Non-Alcoholic Fatty Liver Disease Resolution in Bariatric Surgery Patients. Nutrients 15 (14) (2023)
Guillermo Quintas, Florian Caiment, Iván Rienda, Judith Pérez-Rojas, Eugenia Pareja, José Vicente Castell, Ramiro Jover
Quantitative Prediction of Steatosis in Patients with Non-Alcoholic Fatty Liver by Means of Hepatic MicroRNAs Present in Serum and Correlating with Hepatic Fat. International journal of molecular sciences 23 (16) (2022)
Marta Moreno-Torres, Guillermo Quintas, José Vicente Castell
The Potential Role of Metabolomics in Drug-Induced Liver Injury (DILI) Assessment. Metabolites 12 (6) (2022)
Guillem Garcia-Llorens, Sergi Lopez-Navarro, Teresa Jaijo, José Vicente Castell, Roque Bort
Modeling a Novel Variant of Glycogenosis IXa Using a Clonal Inducible Reprogramming System to Generate "Diseased" Hepatocytes for Accurate Diagnosis. Journal of personalized medicine 12 (7) (2022)
Rubén Rodríguez-Agudo, Naroa Goikoetxea-Usandizaga, Marina Serrano-Maciá, Pablo Fernández-Tussy, David Fernández-Ramos, Sofia Lachiondo-Ortega, Irene González-Recio, Clàudia Gil-Pitarch, María Mercado-Gómez, Laura Morán, Maider Bizkarguenaga, Fernando Lopitz-Otsoa, Petar Petrov, Miren Bravo, Sebastiaan Martijn Van Liempd, Juan Manuel Falcon-Perez, Amaia Zabala-Letona, Arkaitz Carracedo, José Vicente Castell, Ramiro Jover, Luis Alfonso Martinez-Cruz, Teresa Cardoso Delgado, Francisco Javier Cubero, María Isabel Lucena, Raúl Jesús Andrade, Jon Mabe, Jorge Simon, María Luz Martínez-Chantar
Methionine Cycle Rewiring by Targeting miR-873-5p Modulates Ammonia Metabolism to Protect the Liver from Acetaminophen. Antioxidants (Basel, Switzerland) 11 (5) (2022)
Laia Tolosa, Teresa Martínez-Sena, Johannes P Schimming, Erika Moro, Sylvia E Escher, Bas Ter Braak, Bob van de Water, Miguel A Miranda, Barbara M A van Vugt-Lussenburg, José Vicente Castell
The in vitro assessment of the toxicity of volatile, oxidisable, redox-cycling compounds: phenols as an example. Archives of toxicology 95 (6) (2021)
Guillermo Quintas, Teresa Martínez-Sena, Isabel Conde, Eugenia Pareja Ibars, Jos Kleinjans, José Vicente Castell
Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes. Archives of toxicology 95 (9) (2021)
Petar D Petrov, María Leonor Fernández-Murga, Isabel Conde, Teresa Martínez-Sena, Carla Guzmán, José Vicente Castell, Ramiro Jover
Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes. Archives of toxicology 94 (2) (2020)
Teresa Martínez-Sena, Polina Soluyanova, Carla Guzmán, Jose Manuel Valdivielso, José Vicente Castell, Ramiro Jover
The Vitamin D Receptor Regulates Glycerolipid and Phospholipid Metabolism in Human Hepatocytes. Biomolecules 10 (3) (2020)
Petar D Petrov, María Leonor Fernández-Murga, Mireia López-Riera, M José Goméz-Lechón, José Vicente Castell, Ramiro Jover
Predicting drug-induced cholestasis: preclinical models. Expert opinion on drug metabolism & toxicology 14 (7) (2018)